Cargando…
Ginsenoside Rg1 reduces β-amyloid levels by inhibiting CDK5-induced PPARγ phosphorylation in a neuron model of Alzheimer's disease
The accumulation of β-amyloid peptides (Aβ) in the brain is a hallmark of Alzheimer's disease (AD). Studies have indicated that ginsenoside Rg1, a primary component of ginseng (Panax ginseng), reduces brain Aβ levels in an AD model through peroxisome proliferator-activated receptor γ (PPARγ), t...
Autores principales: | Quan, Qiankun, Li, Xi, Feng, Jianjun, Hou, Jixing, Li, Ming, Zhang, Bingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453505/ https://www.ncbi.nlm.nih.gov/pubmed/32945455 http://dx.doi.org/10.3892/mmr.2020.11424 |
Ejemplares similares
-
Pioglitazone Reduces β Amyloid Levels via Inhibition of PPARγ Phosphorylation in a Neuronal Model of Alzheimer’s Disease
por: Quan, Qiankun, et al.
Publicado: (2019) -
Ginsenoside Rg1 Decreases Aβ(1–42) Level by Upregulating PPARγ and IDE Expression in the Hippocampus of a Rat Model of Alzheimer's Disease
por: Quan, QianKun, et al.
Publicado: (2013) -
Cellular and molecular mechanisms underlying the action of ginsenoside Rg1 against Alzheimer's disease☆
por: Li, Xi, et al.
Publicado: (2012) -
Ginsenoside Rg3 has effects comparable to those of ginsenoside re on diabetic kidney disease prevention in db/db mice by regulating inflammation, fibrosis and PPARγ
por: Sui, Zhe, et al.
Publicado: (2023) -
Global analysis of ginsenoside Rg1 protective effects in β-amyloid-treated neuronal cells
por: Shim, Ji Seon, et al.
Publicado: (2017)